These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 20662313)
1. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders. Du B; Li XT; Zhao Y; A YM; Zhang ZZ Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313 [TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Kocbek P; Baumgartner S; Kristl J Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459 [TBL] [Abstract][Full Text] [Related]
3. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Ali HS; York P; Blagden N Int J Pharm; 2009 Jun; 375(1-2):107-13. PubMed ID: 19481696 [TBL] [Abstract][Full Text] [Related]
4. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297 [TBL] [Abstract][Full Text] [Related]
5. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology]. Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833 [TBL] [Abstract][Full Text] [Related]
6. Comminution of ibuprofen to produce nano-particles for rapid dissolution. Plakkot S; de Matas M; York P; Saunders M; Sulaiman B Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776 [TBL] [Abstract][Full Text] [Related]
7. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096 [TBL] [Abstract][Full Text] [Related]
8. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Gao L; Liu G; Wang X; Liu F; Xu Y; Ma J Int J Pharm; 2011 Feb; 404(1-2):231-7. PubMed ID: 21093559 [TBL] [Abstract][Full Text] [Related]
9. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274 [TBL] [Abstract][Full Text] [Related]
10. Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques. Vaughn JM; Gao X; Yacaman MJ; Johnston KP; Williams RO Eur J Pharm Biopharm; 2005 May; 60(1):81-9. PubMed ID: 15848060 [TBL] [Abstract][Full Text] [Related]
11. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution. Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838 [TBL] [Abstract][Full Text] [Related]
13. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545 [TBL] [Abstract][Full Text] [Related]
14. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Freag MS; Elnaggar YS; Abdallah OY Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765 [TBL] [Abstract][Full Text] [Related]
15. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Van Eerdenbrugh B; Froyen L; Martens JA; Blaton N; Augustijns P; Brewster M; Van den Mooter G Int J Pharm; 2007 Jun; 338(1-2):198-206. PubMed ID: 17363200 [TBL] [Abstract][Full Text] [Related]
16. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Dolenc A; Kristl J; Baumgartner S; Planinsek O Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794 [TBL] [Abstract][Full Text] [Related]
17. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying. Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973 [TBL] [Abstract][Full Text] [Related]
18. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide. Sahu BP; Das MK Acta Pol Pharm; 2014; 71(1):129-37. PubMed ID: 24779201 [TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility. Potta SG; Minemi S; Nukala RK; Peinado C; Lamprou DA; Urquhart A; Douroumis D J Microencapsul; 2011; 28(1):74-81. PubMed ID: 21171818 [TBL] [Abstract][Full Text] [Related]
20. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Hu J; Ng WK; Dong Y; Shen S; Tan RB Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]